Evidence map›Paper›PMID 34187516›Full record

ArticleOrphanet journal of rare diseases2021

Metabolic and immunological phenotype of rare lipomatoses: Dercum's disease and Roch-Leri mesosomatic lipomatosis.

Madleen Lemaitre, Benjamin Chevalier, Arnaud Jannin, Kristell Le Mapihan, Samuel Boury, Georges Lion, Myriam Labalette, Marie-Christine Vantyghem

Registry-linked trialOpen access · goldAbstract read
In one paragraph

Article in Orphanet journal of rare diseases, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01784289 (Adipocyte, Insulin-resistance and Immunity), which is not on this map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
1.0field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01784289 completednot on this map

Adipocyte, Insulin-resistance and Immunity : Evaluation of Interleukin-7 in Lipodystrophies According to Fat Mass and Glucose Metabolism

TypeobservationalSponsorUniversity Hospital, LilleRan2010 to 2015Enrolled126ConditionsLipodystrophy, Obesity, Type 2 Diabetes
3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 7 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 1 country.

Madleen LemaitreEndocrinology, Diabetology and Metabolism, CHU Lille, 59000, Lille, France. madleen.lemaitre@chru-lille.fr.ORCID 0000-0002-3203-717X
Benjamin ChevalierEndocrinology, Diabetology and Metabolism, CHU Lille, 59000, Lille, France.
Arnaud JanninEndocrinology, Diabetology and Metabolism, CHU Lille, 59000, Lille, France.
Kristell Le MapihanEndocrinology, Diabetology and Metabolism, CHU Lille, 59000, Lille, France.
Samuel BouryNuclear Medicine Department, CHU Lille, 59000, Lille, France.
Georges LionNuclear Medicine Department, CHU Lille, 59000, Lille, France.
Myriam LabaletteInstitute of Immunology, CHU Lille, 59000, Lille, France.
Marie-Christine VantyghemEndocrinology, Diabetology and Metabolism, CHU Lille, 59000, Lille, France. mc-vantyghem@chru-lille.fr.
Université de Lille · FRCentre Hospitalier Universitaire de Lille · FRInserm · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

contextDercum's disease (DD) and Roch-Leri mesosomatic lipomatosis (LMS) are rare and poorly characterized diseases. The clinical presentation combines multiple lipomas, painful in DD in contrast with LMS, without lipoatrophy.

objectiveTo identify any specific metabolic and immune phenotype of DD and LMS. DESIGN AND PATIENTS: This monocentric retrospective study included 46 patients: 9 DD, 11 LMS, 18 lean and 8 obese controls. Metabolic and immunohematological characteristics of each group were compared.

resultsThe median age of the patients was similar in the 3 groups (31 years). The number of women, and of basophils, and CD3

conclusionDD and LMS show a common background of obesity and metabolic phenotype, but a distinct immunohematological profile characterized by a higher number of basophils in DD patients, an inflammatory profile that could contribute to pain. T lymphocyte depletion was present in LMS. These findings could offer specific therapeutic opportunities, especially for painful DD.

Indexed as

Adiposis DolorosaLipomatosisAdultFemaleHumansObesityPhenotypeRetrospective StudiesBasophilCD3CD4 (cluster differentiation 4)CD8Dercum’s diseaseLipodystrophyLipomatosisNatural killerRoch-LeriT lymphocyte

Identifiers

PMID34187516
PMCPMC8243498
OpenAlexW3145696355

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.